Professor Ian Frazer

Professor

Faculty of Medicine

Affiliate Professor

The University of Queensland Diamantina Institute
Faculty of Medicine

Affil Professorial Research Fellow

Institute for Molecular Bioscience
i.frazer@uq.edu.au
+61 7 344 38042

Overview

Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council. Most recently appointed chair of the federal governments Medical Research Future Fund.

He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.

Qualifications

  • Honorary Degree of Doctor of Science, University of Edinburgh
  • Doctor of Medicine, University of Melbourne
  • FRCPA
  • FRCP (Ed)
  • MB ChB, University of Edinburgh
  • Bachelor of Science (Honours), University of Edinburgh

Publications

View all Publications

Grants

View all Grants

Supervision

View all Supervision

Publications

Book

Book Chapter

  • Frazer, Ian H. (2010). Human papillomaviruses. In Andrew W. Artenstein (Ed.), Vaccines: a biography (pp. 361-373) New York, United States: Springer. doi:10.1007/978-1-4419-1108-7_21

  • Jansen, Kathrin U. and Frazer, Ian H. (2010). Vaccines against human papillomaviruses. In Myron M. Levine (Ed.), New generation vaccines 4th ed. (pp. 954-961) New York, U.S.A.: Informa Healthcare.

  • Frazer, Ian H. (2009). Vaccines against human papillomavirus infection. In Levine, M. M (Ed.), Vaccines against human papillomavirus infection 4th ed. (pp. 977-986) United States: Informa Healthcare.

  • Frazer, I.H. and Appleton. S. (2007). Vaccines to prevent and treat human papillomavirus associated anogenital disease. In Jordan, J., Singer, A. and et al. (Ed.), The Cervix (pp. 609-621) United States: Blackwell publishing.

  • Edwards, S. J., Basser, R. L. and Frazer, I. H. (2005). Development of a Vaccine Against Human Papillomavirus (HPV. In Philippe Moingeon Stallergenes (Ed.), Vaccines: Frontiers in Design and Development (pp. 210-230) United Kingdom: Horizon Bioscience.

  • Frazer, I. H. (2004). Human Papillomavirus. In Ciro A. de Quadros (Ed.), Vaccines: Preventing Disease & Protecting Health 1 ed. (pp. 140-143) Washington, D.C.: Pan American Health Organisation.

  • Boslego, J., Liu, X. and Frazer, I. H. (2004). Vaccines Against Human Papillomavirus Infection. In Myron M. Levine, James B. Kaper, Rino Rappuoli, Margaret A. Liu and Michael F. Good (Ed.), New Generation Vaccines 3 ed. (pp. 977-986) New York: Marcel Dekker, Inc..

  • Frazer, I. H. (2001). Wart and hepatitis vaccines. In D. L. Healy, R. McLachlan, G. T. Kovacs and O. Rodriguex-Armas (Ed.), Reproductive medicine in the twenty first century 1st ed. (pp. 173-181) UK: The Parthenon Publishing Group Ltd.

  • Frazer, I. H. and Tindle, R. (1999). Cell mediated immunity to papillomaviruses. In Charles Lacey (Ed.), Current research on papillomaviruses (pp. 151-164) Leeds, England: Leeds University Press.

  • Leggatt, G. R. and Frazer, I. H. (1999). Immunology of HPV infection. In Robert W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease (pp. 13-31) Austin, USA: R. G. Landes Company.

  • Frazer, I. H. and Dunn, L. A. (1999). Papillomavirus. In Rafi Ahmed and Irvin S.Y. Chen (Ed.), Persistent Viral Infections (pp. 131-146) Chichester, USA: John Wiley & Sons.

  • Frazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. In R. W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease (pp. 91-104) Austin, USA: R.G. Landes Company.

Journal Article

Conference Publication

Other Outputs

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

    Other advisors:

  • Doctor Philosophy — Associate Advisor

Completed Supervision